References
- Schaefer J, Saak A, Bönnemann CG, Jackson S. Myogenic tremor – a novel tremor entity. Curr Opin Neurol. 2021 Oct; 34(5): 706–713. DOI: 10.1097/WCO.0000000000000976
- Wang L, Geist J, Grogan A, Hu LYR, Kontrogianni-Konstantopoulos A. Thick Filament Protein Network, Functions, and Disease Association. Compr Physiol. 2018 Apr; 8(2): 631–709. DOI: 10.1002/cphy.c170023
- Ruppel KM, Spudich JA. Structure-function analysis of the motor domain of myosin. Annu Rev Cell Dev Biol. 1996; 12: 543–573. DOI: 10.1146/annurev.cellbio.12.1.543
- Lossos A, Oldfors A, Fellig Y, Meiner V, Argov Z, Tajsharghi H. MYH2 mutation in recessive myopathy with external ophthalmoplegia linked to chromosome 17p13.1-p12. Brain. 2013 Jul; 136(7): e238–e238. DOI: 10.1093/BRAIN/AWS365
- Cassini TA, Malicdan MCV, Macnamara EF, Lehky T, Horkayne-Szakaly I, Huang Y, et al. MYH2-associated myopathy caused by a novel splice-site variant. Neuromuscul Disord. 2023 Mar; 33(3): 257–262. DOI: 10.1016/j.nmd.2022.12.014
- Telese R, Pagliarani S, Lerario A, Ciscato P, Fagiolari G, Cassandrini D, et al. MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form. Mol Genet Genomic Med. 2020; 8(9): 1–9. DOI: 10.1002/mgg3.1320
- Martinsson T, Oldfors A, Darin N, Berg K, Tajsharghi H, Kyllerman M, et al. Autosomal dominant myopathy: missense mutation (Glu-706 → Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci USA. 2000 Dec; 97(26): 14614–14619. DOI: 10.1073/pnas.250289597
- Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019; 176(3): 535–548. DOI: 10.1016/j.cell.2018.12.015
- Walker LC, Hoya M dela, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet. 2023 Jul; 110(7): 1046–1067. DOI: 10.1016/j.ajhg.2023.06.002
- Schubach M, Maass T, Nazaretyan L, Röner S, Kircher M. CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions. Nucleic Acids Res. 2024 Jan; 52(D1): D1143–D1154. DOI: 10.1093/nar/gkad989
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine. 2015 May; 17(5): 405–424. DOI: 10.1038/gim.2015.30
- Tajsharghi H, Darin N, Rekabdar E, Kyllerman M, Wahlström J, Martinsson T, et al. Mutations and sequence variation in the human myosin heavy chain IIa gene (MYH2). European Journal of Human Genetics. 2005; 13(5): 617–622. DOI: 10.1038/sj.ejhg.5201375
- Tajsharghi H, Hammans S, Lindberg C, Lossos A, Clarke NF, Mazanti I, et al. Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations. Eur J Hum Genet. 2014; 22(6): 801–808. DOI: 10.1038/ejhg.2013.250
- Maniyar AMH, Singh RK, Ojha PT, Chaudhary GS, Mahto AP, Shah AG. Myosin Myopathy Presenting as Chronic Progressive External Ophthalmoplegia. Ann Indian Acad Neurol. 2023; 26(6): 1024–1025. DOI: 10.4103/AIAN.AIAN_552_23
- Tajsharghi H, Hilton-Jones D, Raheem O, Saukkonen AM, Oldfors A, Udd B. Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations. Brain. 2010; 133(5): 1451–1459. DOI: 10.1093/brain/awq083
- Darin N, Kyllerman M, Wahlström J, Martinsson T, Oldfors A. Autosomal dominant myopathy with congenital joint contractures, ophthalmoplegia, and rimmed vacuoles. Ann Neurol. 1998 Aug; 44(2): 242–248. DOI: 10.1002/ana.410440215
- Hauserman JG, Stavusis J, Joca HC, Robinett JC, Hanft L, Vandermeulen J, et al. Sarcomeric deficits underlie MYBPC1 associated myopathy with myogenic tremor. JCI Insight. 2021 Oct; 6(19). DOI: 10.1172/jci.insight.147612